| 1 | Hydatidiform Mole | 34.5% |
| 2 | Cystadenocarcinoma | 30.9% |
| 3 | Mucoepidermoid Carcinoma | 30.9% |
| 4 | Neoplasms, Neuroepithelial | 30.4% |
| 5 | Gliomatosis cerebri | 30.4% |
| 6 | Carcinoid Tumor | 29.4% |
| 7 | Neuroectodermal Tumors | 28.9% |
| 8 | Basal cell carcinoma | 27.5% |
| 9 | Carcinoma, Papillary | 27.5% |
| 10 | Squamous cell carcinoma | 27.5% |
| 11 | Carcinoma, Basal Cell | 27.5% |
| 12 | Carcinoma, Lobular | 27.1% |
| 13 | Carcinoma, Ehrlich Tumor | 25.8% |
| 14 | Carcinoma, Lewis Lung | 25.8% |
| 15 | Adenoid Cystic Carcinoma | 24.5% |
| 16 | Adenocarcinoma, Clear Cell | 24.5% |
| 17 | Cholangiocarcinoma | 24.5% |
| 18 | Malignant Carcinoid Syndrome | 23.2% |
| 19 | leukemia | 22.8% |
| 20 | Medulloblastoma | 22.6% |
| 21 | melanoma | 21.5% |
| 22 | Chordoma | 21.2% |
| 23 | Teratoma | 21.2% |
| 24 | Germinoma | 21.2% |
| 25 | Teratocarcinoma | 21.2% |
| 26 | Cystadenoma | 21% |
| 27 | Mesothelioma | 21% |
| 28 | Adenoma, Acidophil | 20.9% |
| 29 | Ganglioneuroma | 20.9% |
| 30 | Glioma | 20.9% |
| 31 | Malignant Glioma | 20.9% |
| 32 | Carcinoma in Situ | 20.4% |
| 33 | Carcinoma, Transitional Cell | 20.4% |
| 34 | Carcinoma, Large Cell | 20.4% |
| 35 | Carcinoma, Small Cell | 20.4% |
| 36 | Dermoid Cyst | 20.3% |
| 37 | Adenoma | 19.9% |
| 38 | Bowen's Disease | 19.3% |
| 39 | Histiocytic Disorders, Malignant | 19% |
| 40 | Craniopharyngioma | 18.9% |
| 41 | Neuroectodermal Tumor, Melanotic | 18.9% |
| 42 | Neuroendocrine Tumors | 18.9% |
| 43 | Klatskin Tumor | 18.8% |
| 44 | Meningioma | 18.7% |
| 45 | Hamartoma | 18.6% |
| 46 | Neoplasms, Hormone-Dependent | 18.6% |
| 47 | Neoplasms, Multiple Primary | 18.6% |
| 48 | Paraneoplastic Syndromes | 18.6% |
| 49 | Precancerous Conditions | 18.6% |
| 50 | Neoplasms, Second Primary | 18.6% |
| 51 | Carcinosarcoma | 18.4% |
| 52 | Hemangiosarcoma | 18.4% |
| 53 | lymphangiosarcoma | 18.4% |
| 54 | Melanoma, Experimental | 18.2% |
| 55 | Carcinoma 256, Walker | 18.2% |
| 56 | Carcinoid Heart Disease | 17.9% |
| 57 | Leukemia, Experimental | 16.9% |
| 58 | Composite Lymphoma | 16.7% |
| 59 | Carcinoma, Pancreatic Ductal | 16.6% |
| 60 | Neurilemmoma | 16.5% |
| 61 | Lymphoma | 16.3% |
| 62 | Astrocytoma | 16.2% |
| 63 | Ependymoma | 16.2% |
| 64 | oligodendroglioma | 16.2% |
| 65 | Ganglioglioma | 16.2% |
| 66 | gliosarcoma | 16.2% |
| 67 | Anaplastic astrocytoma | 16.2% |
| 68 | Anaplastic Oligodendroglioma | 16.2% |
| 69 | Hutchinson's Melanotic Freckle | 16.1% |
| 70 | Melanoma, Amelanotic | 16.1% |
| 71 | Leukemia, Plasma Cell | 15.8% |
| 72 | Acanthoma | 15.7% |
| 73 | Cyst | 15.7% |
| 74 | Neoplastic Processes | 15.7% |
| 75 | Neoplastic Syndromes, Hereditary | 15.7% |
| 76 | Neoplasms, Experimental | 15.5% |
| 77 | Retinoblastoma | 15.5% |
| 78 | Adrenocortical carcinoma | 15.4% |
| 79 | Vipoma | 15.3% |
| 80 | Multiple Endocrine Neoplasia | 15.1% |
| 81 | Leukemia, Radiation-Induced | 15% |
| 82 | Adenofibroma | 14.9% |
| 83 | Fibroadenoma | 14.9% |
| 84 | Carcinoma, Endometrioid | 14.8% |
| 85 | Renal Cell Carcinoma | 14.8% |
| 86 | Papillary Renal Cell Carcinoma | 14.8% |
| 87 | Chondrosarcoma | 14.6% |
| 88 | leiomyosarcoma | 14.6% |
| 89 | liposarcoma | 14.6% |
| 90 | synovial sarcoma | 14.6% |
| 91 | Angiomyolipoma | 14.6% |
| 92 | Clear Cell Sarcoma of Soft Tissue | 14.6% |
| 93 | Alveolar Soft Part Sarcoma | 14.6% |
| 94 | Sarcoma, Myeloid | 14.6% |
| 95 | Basal Cell Nevus Syndrome | 14.2% |
| 96 | Cervical Intraepithelial Neoplasia | 14.2% |
| 97 | Paraganglioma | 13.9% |
| 98 | Glioblastoma | 13.9% |
| 99 | Neuroblastoma | 13.9% |
| 100 | Glioblastoma Multiforme | 13.9% |
| 101 | Dysgerminoma | 13.9% |
| 102 | Seminoma | 13.9% |
| 103 | Neoplasms, Glandular and Epithelial | 13.9% |
| 104 | Sarcoma, Experimental | 13.6% |
| 105 | Ameloblastoma | 13.4% |
| 106 | Angiokeratoma | 13.4% |
| 107 | Hemangioma | 13.4% |
| 108 | hemangiopericytoma | 13.4% |
| 109 | Lymphangioma | 13.4% |
| 110 | Mesenchymoma | 13.4% |
| 111 | Nevus | 13.4% |
| 112 | Hepatoblastoma | 13.4% |
| 113 | Mixed Tumor, Mullerian | 13.4% |
| 114 | Angiofibroma | 13.4% |
| 115 | Sarcoma | 13.4% |
| 116 | Neoplasms, Radiation-Induced | 13.3% |
| 117 | Endometrial Stromal Sarcoma | 13.2% |
| 118 | Carcinoma, Ovarian Epithelial | 13.2% |
| 119 | Neoplasms, Germ Cell and Embryonal | 12.9% |
| 120 | Germ Cell Cancer | 12.9% |
| 121 | Ganglioneuroblastoma | 12.8% |
| 122 | Fibrosarcoma | 12.6% |
| 123 | Osteosarcoma | 12.6% |
| 124 | Papilloma | 12.6% |
| 125 | Pseudomyxoma Peritonei | 12.6% |
| 126 | Papillomatosis | 12.6% |
| 127 | Adenomatosis, Pulmonary | 12.6% |
| 128 | Adenomatous Polyps | 12.6% |
| 129 | Gastrinoma | 12.6% |
| 130 | Glucagonoma | 12.6% |
| 131 | Thymoma | 12.6% |
| 132 | Leukemia L1210 | 12.5% |
| 133 | Leukemia P388 | 12.5% |
| 134 | Tuberous Sclerosis | 12% |
| 135 | Nephroblastoma | 12% |
| 136 | Paraneoplastic Encephalomyelitis | 11.9% |
| 137 | Mammary Neoplasms, Experimental | 11.8% |
| 138 | Malignant Fibrous Histiocytoma | 11.7% |
| 139 | Pheochromocytoma | 11.5% |
| 140 | Plasmacytoma | 11.2% |
| 141 | Malignant histiocytosis | 11.1% |
| 142 | Histiocytic sarcoma | 11.1% |
| 143 | Lymphangioleiomyomatosis | 10.9% |
| 144 | Rhabdomyosarcoma | 10.7% |
| 145 | Giant Cell Tumor of Bone | 10.7% |
| 146 | Hepatocellular Adenoma | 10.6% |
| 147 | Sarcoma 180 | 10.5% |
| 148 | Nasopharyngeal carcinoma | 10.5% |
| 149 | Lymphomatoid Granulomatosis | 10.3% |
| 150 | Acoustic Neuroma | 10.3% |
| 151 | Optic Nerve Glioma | 10.3% |
| 152 | Abdominal Neoplasms | 10.2% |
| 153 | Erythroplasia | 10.2% |
| 154 | Follicular cyst | 10.2% |
| 155 | Head and Neck Neoplasms | 10.2% |
| 156 | Mucocele | 10.2% |
| 157 | Pilonidal Cyst | 10.2% |
| 158 | Soft Tissue Neoplasms | 10.2% |
| 159 | Thoracic Neoplasms | 10.2% |
| 160 | Thyroglossal Cyst | 10.2% |
| 161 | Synovial Cyst | 10.2% |
| 162 | Aberrant Crypt Foci | 10.2% |
| 163 | Neurofibrosarcoma | 10% |
| 164 | Pregnancy Complications, Neoplastic | 10% |
| 165 | Trophoblastic Neoplasms | 9.9% |
| 166 | Polyhydramnios | 9.9% |
| 167 | Obstetric Labor Complications | 9.9% |
| 168 | Ectopic Pregnancy | 9.9% |
| 169 | Pregnancy, Prolonged | 9.9% |
| 170 | Puerperal Disorders | 9.9% |
| 171 | Oligohydramnios | 9.9% |
| 172 | Prenatal Injuries | 9.9% |
| 173 | Chorioamnionitis | 9.9% |
| 174 | Abruptio Placentae | 9.8% |
| 175 | Placenta Accreta | 9.8% |
| 176 | Dermatofibrosarcoma | 9.8% |
| 177 | Dermatofibrosarcoma Protuberans | 9.8% |
| 178 | Hodgkin Disease | 9.5% |
| 179 | Lymphoma, Non-Hodgkin | 9.5% |
| 180 | Prolactinoma | 9.4% |
| 181 | Growth Hormone-Secreting Pituitary Adenoma | 9.4% |
| 182 | Multiple Endocrine Neoplasia Type 1 | 9.3% |
| 183 | Mesoblastic Nephroma | 9.2% |
| 184 | Digestive System Neoplasms | 8.8% |
| 185 | Endocrine Gland Neoplasms | 8.8% |
| 186 | Eye Neoplasms | 8.8% |
| 187 | Nervous System Neoplasms | 8.8% |
| 188 | Alveolar rhabdomyosarcoma | 8.8% |
| 189 | Phyllodes Tumor | 8.7% |
| 190 | Hemangioendothelioma | 8.7% |
| 191 | Lipoma | 8.7% |
| 192 | Myoma | 8.7% |
| 193 | Myxoma | 8.7% |
| 194 | Neuroma | 8.7% |
| 195 | Angiolipoma | 8.7% |
| 196 | Myelolipoma | 8.7% |
| 197 | Neoplasms, Bone Tissue | 8.7% |
| 198 | Neoplasms, Fibrous Tissue | 8.7% |
| 199 | Smooth Muscle Tumor | 8.7% |
| 200 | Desmoplastic Small Round Cell Tumor | 8.7% |
| 201 | Chondroma | 8.7% |
| 202 | Enchondroma | 8.7% |
| 203 | Bone neoplasms | 8.6% |
| 204 | Leukoplakia | 8.6% |
| 205 | Lymphocele | 8.6% |
| 206 | Pancreatic Cyst | 8.6% |
| 207 | Skin Neoplasms | 8.6% |
| 208 | Hematologic Neoplasms | 8.6% |
| 209 | Fetal Diseases | 8.5% |
| 210 | Pregnancy Complications, Cardiovascular | 8.5% |
| 211 | Barrett Esophagus | 8.5% |
| 212 | Breast Cyst | 8.5% |
| 213 | Actinic keratosis | 8.5% |
| 214 | Mediastinal Cyst | 8.5% |
| 215 | Neoplasm Invasiveness | 8.5% |
| 216 | Neoplasm Metastasis | 8.5% |
| 217 | Neoplasm Recurrence, Local | 8.5% |
| 218 | Parovarian Cyst | 8.5% |
| 219 | Pericardial Cyst | 8.5% |
| 220 | Splenic Neoplasms | 8.5% |
| 221 | Thymic Cyst | 8.5% |
| 222 | Carcinogenesis | 8.5% |
| 223 | Myxoid cyst | 8.5% |
| 224 | Metastasis | 8.5% |
| 225 | Carcinoma | 8.5% |
| 226 | Epithelioma | 8.5% |
| 227 | Puerperal Infection | 8.4% |
| 228 | Adenomatous Polyposis Coli | 8.4% |
| 229 | Postpartum Hemorrhage | 8.4% |
| 230 | Primary amyloidosis | 8.4% |
| 231 | Pregnancy Complications, Hematologic | 8.4% |
| 232 | Pregnancy Complications, Infectious | 8.4% |
| 233 | Fetal Death | 8.3% |
| 234 | Perinatal death | 8.3% |
| 235 | Morning Sickness | 8.2% |
| 236 | Choriocarcinoma | 8.1% |
| 237 | Liver Neoplasms, Experimental | 8% |
| 238 | Corpus Luteum Cyst | 8% |
| 239 | Ovarian Cysts | 8% |
| 240 | Parathyroid Neoplasms | 7.9% |
| 241 | Peritoneal Neoplasms | 7.9% |
| 242 | Thyroid Neoplasm | 7.9% |
| 243 | Thyroid carcinoma | 7.9% |
| 244 | insulinoma | 7.7% |
| 245 | granulosa cell tumor | 7.3% |
| 246 | Leukemia, Myelomonocytic, Chronic | 7.3% |
| 247 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.3% |
| 248 | Gestational Diabetes | 7.1% |
| 249 | Pancreatic Neoplasm | 7.1% |
| 250 | Genital Neoplasms, Female | 6.8% |
| 251 | Waldenstrom Macroglobulinemia | 6.7% |
| 252 | Multiple Myeloma | 6.7% |
| 253 | Tracheal Neoplasms | 6.7% |
| 254 | Leukoplakia, Oral | 6.5% |
| 255 | Paraneoplastic Cerebellar Degeneration | 6.5% |
| 256 | Choledochal Cyst | 6.5% |
| 257 | fibroma | 6.5% |
| 258 | Fibromatosis | 6.5% |
| 259 | Osteoblastoma | 6.5% |
| 260 | Osteoma | 6.5% |
| 261 | Rhabdomyoma | 6.5% |
| 262 | Chondromatosis | 6.5% |
| 263 | Hemangioblastoma | 6.5% |
| 264 | Lymphoma, Extranodal NK-T-Cell | 6.5% |
| 265 | Mastocytosis | 6.4% |
| 266 | Sturge-Weber Syndrome | 6.4% |
| 267 | Peutz-Jeghers Syndrome | 6.3% |
| 268 | Gastrointestinal Stromal Tumors | 6.3% |
| 269 | Denys-Drash Syndrome | 6.3% |
| 270 | Hemangioma, Cavernous | 6.3% |
| 271 | Leukemia, T-Cell | 6.2% |
| 272 | Leukemia, B-Cell | 6.2% |
| 273 | neurofibroma | 6.2% |
| 274 | Lymphoma, Follicular | 6.2% |
| 275 | T-Cell Lymphoma | 6.2% |
| 276 | Mantle cell lymphoma | 6.2% |
| 277 | Retroperitoneal Neoplasms | 6.2% |
| 278 | Female Urogenital Diseases | 6.1% |
| 279 | Uterine Inversion | 6% |
| 280 | Urologic Neoplasms | 5.9% |
| 281 | Abortion, Habitual | 5.9% |
| 282 | Dystocia | 5.9% |
| 283 | Eclampsia | 5.9% |
| 284 | Fetal Membranes, Premature Rupture | 5.9% |
| 285 | Placental Insufficiency | 5.9% |
| 286 | Pre-Eclampsia | 5.9% |
| 287 | Prenatal Exposure Delayed Effects | 5.9% |
| 288 | HELLP Syndrome | 5.9% |
| 289 | Placenta, Retained | 5.9% |
| 290 | Esophageal Neoplasms | 5.8% |
| 291 | Adenocarcinoma | 5.8% |
| 292 | Limbic Encephalitis | 5.8% |
| 293 | Leydig Cell Tumor | 5.6% |
| 294 | Mastocytoma | 5.4% |
| 295 | Mastocytosis, Systemic | 5.4% |
| 296 | Leukemia, Myeloid, Chronic-Phase | 5.4% |
| 297 | Fibromatosis, Aggressive | 5.3% |
| 298 | Fibromatosis, Abdominal | 5.3% |
| 299 | Thyroid Nodule | 5.3% |
| 300 | Lambert-Eaton Myasthenic Syndrome | 5.3% |
| 301 | Testicular Neoplasms | 5.3% |
| 302 | Mouth Neoplasms | 5.2% |
| 303 | Central Nervous System Neoplasms | 5.2% |
| 304 | Vascular Neoplasms | 5.2% |
| 305 | Thymus Neoplasms | 5.2% |
| 306 | Pancreatic Pseudocyst | 5.2% |
| 307 | Uterine Rupture | 5.2% |
| 308 | Lymphatic Metastasis | 5.1% |
| 309 | Neoplasms, Unknown Primary | 5.1% |
| 310 | Leukemic Infiltration | 5.1% |
| 311 | Breast Neoplasms, Male | 5.1% |
| 312 | Neoplasm Micrometastasis | 5.1% |
| 313 | Triple Negative Breast Neoplasms | 5.1% |
| 314 | Abortion, Veterinary | 5.1% |
| 315 | Pregnancy Complications, Parasitic | 5.1% |
| 316 | Polycystic Ovary Syndrome | 5% |
| 317 | Lactation Disorder | 4.9% |
| 318 | Mastitis | 4.9% |
| 319 | Depression, Postpartum | 4.9% |
| 320 | Embryo Loss | 4.9% |
| 321 | Fetal Resorption | 4.9% |
| 322 | Hyperemesis Gravidarum | 4.9% |
| 323 | Uterine Neoplasms | 4.8% |
| 324 | Vaginal Neoplasms | 4.8% |
| 325 | Vulvar Neoplasms | 4.8% |
| 326 | Uterine Cancer | 4.8% |
| 327 | Opsoclonus-Myoclonus Syndrome | 4.8% |
| 328 | ovarian neoplasm | 4.7% |
| 329 | Fallopian Tube Neoplasms | 4.6% |
| 330 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 4.6% |
| 331 | Leukemia, Large Granular Lymphocytic | 4.6% |
| 332 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 4.6% |
| 333 | Lymphoma, T-Cell, Cutaneous | 4.6% |
| 334 | Lymphoma, AIDS-Related | 4.6% |
| 335 | Enteropathy-Associated T-Cell Lymphoma | 4.6% |
| 336 | Primary Effusion Lymphoma | 4.6% |
| 337 | Adrenal Gland Neoplasms | 4.5% |
| 338 | Gastrointestinal Neoplasms | 4.5% |
| 339 | Genital Neoplasms, Male | 4.5% |
| 340 | Liver neoplasms | 4.5% |
| 341 | Uveal Neoplasms | 4.5% |
| 342 | Sebaceous Gland Neoplasms | 4.4% |
| 343 | Spinal Neoplasms | 4.4% |
| 344 | Bone Marrow Neoplasms | 4.4% |
| 345 | Myelitis, Transverse | 4.4% |
| 346 | Xeroderma Pigmentosum | 4.3% |
| 347 | Fetal Growth Retardation | 4.3% |
| 348 | Embolism, Amniotic Fluid | 4.2% |
| 349 | Fetal Hypoxia | 4.2% |
| 350 | Fetal Alcohol Spectrum Disorders | 4.2% |
| 351 | Breech Presentation | 4.2% |
| 352 | Stillbirth | 4.2% |
| 353 | Uterine Cervical Incompetence | 4% |
| 354 | Nose Neoplasms | 4% |
| 355 | Premature Birth | 3.9% |
| 356 | Dupuytren Contracture | 3.9% |
| 357 | Urticaria Pigmentosa | 3.8% |
| 358 | Bladder Neoplasm | 3.8% |
| 359 | Kidney Neoplasm | 3.8% |
| 360 | Ureteral Neoplasms | 3.8% |
| 361 | Urethral Neoplasms | 3.8% |
| 362 | Mycosis Fungoides | 3.8% |
| 363 | Lymphomatoid Papulosis | 3.8% |
| 364 | Plasmablastic lymphoma | 3.8% |
| 365 | Palatal Neoplasms | 3.7% |
| 366 | Endometrial Neoplasms | 3.7% |
| 367 | Pituitary Adenoma | 3.6% |
| 368 | Pituitary Neoplasms | 3.6% |
| 369 | Burkitt Lymphoma | 3.6% |
| 370 | Meningeal Neoplasms | 3.5% |
| 371 | Meconium Aspiration Syndrome | 3.4% |
| 372 | Galactorrhea | 3.2% |
| 373 | Ear Neoplasms | 3.1% |
| 374 | Eyelid Neoplasms | 3.1% |
| 375 | Lung Neoplasms | 3.1% |
| 376 | Pleural Neoplasms | 3.1% |
| 377 | Cell Transformation, Viral | 3% |
| 378 | Brain Neoplasms | 3% |
| 379 | Salivary Gland Neoplasms | 3% |
| 380 | Spinal Cord Neoplasms | 3% |
| 381 | Tongue Neoplasms | 3% |
| 382 | Sezary Syndrome | 3% |
| 383 | Urologic Diseases | 2.8% |
| 384 | Zollinger-Ellison syndrome | 2.8% |
| 385 | Pharyngeal Neoplasms | 2.7% |
| 386 | Meningeal Carcinomatosis | 2.7% |
| 387 | Central Nervous System Cysts | 2.7% |
| 388 | Bile Duct Neoplasms | 2.7% |
| 389 | gallbladder neoplasm | 2.7% |
| 390 | Intestinal Neoplasms | 2.7% |
| 391 | Penile Neoplasms | 2.7% |
| 392 | Prostatic Neoplasms | 2.7% |
| 393 | Stomach Neoplasms | 2.7% |
| 394 | Polycythemia Vera | 2.6% |
| 395 | Urogenital Abnormalities | 2.5% |
| 396 | Laryngeal neoplasm | 2.4% |
| 397 | Bronchial Neoplasms | 2.3% |
| 398 | Multiple Pulmonary Nodules | 2.3% |
| 399 | Supratentorial Neoplasms | 2.3% |
| 400 | Hypopharyngeal Neoplasms | 2% |
| 401 | Pleural Effusion, Malignant | 2% |
| 402 | Hypopharyngeal Cancer | 2% |
| 403 | Parotid Neoplasms | 2% |
| 404 | Prostatic Neoplasms, Castration-Resistant | 2% |
| 405 | Nelson Syndrome | 2% |
| 406 | Endometriosis | 2% |
| 407 | Uterine Diseases | 2% |
| 408 | Vaginal Diseases | 2% |
| 409 | Vulvar Diseases | 2% |
| 410 | Endometrioma | 2% |
| 411 | Brain Stem Neoplasms | 1.9% |
| 412 | Endometritis | 1.9% |
| 413 | Bladder Exstrophy | 1.8% |
| 414 | Epispadias | 1.8% |
| 415 | Tuberculosis, Renal | 1.8% |
| 416 | Cecal Neoplasms | 1.8% |
| 417 | Duodenal Neoplasms | 1.8% |
| 418 | Hydrops Fetalis | 1.8% |
| 419 | Choroid Plexus Papilloma | 1.8% |
| 420 | Tonsillar Neoplasms | 1.7% |
| 421 | Cerebellar Neoplasms | 1.7% |
| 422 | Urinary Bladder Diseases | 1.7% |
| 423 | Infertility | 1.7% |
| 424 | Kidney Diseases | 1.7% |
| 425 | Ureteral Diseases | 1.7% |
| 426 | Urethral Diseases | 1.7% |
| 427 | Urination Disorders | 1.7% |
| 428 | Urolithiasis | 1.7% |
| 429 | Multicystic Dysplastic Kidney | 1.6% |
| 430 | Nasopharyngeal Neoplasms | 1.6% |
| 431 | Anuria | 1.6% |
| 432 | Ureterolithiasis | 1.6% |
| 433 | Nephrolithiasis | 1.6% |
| 434 | Colorectal Neoplasms | 1.6% |
| 435 | Salpingitis | 1.6% |
| 436 | Vulvovaginitis | 1.6% |
| 437 | Vesicovaginal Fistula | 1.6% |
| 438 | Radicular Cyst | 1.5% |
| 439 | Appendiceal Neoplasms | 1.5% |
| 440 | Colonic Neoplasms | 1.5% |
| 441 | Rectal Neoplasms | 1.5% |
| 442 | Paranasal Sinus Neoplasms | 1.5% |
| 443 | Urinary Bladder Fistula | 1.4% |
| 444 | Urinary tract infection | 1.4% |
| 445 | Horseshoe Kidney | 1.4% |
| 446 | Bladder neck obstruction | 1.4% |
| 447 | Oophoritis | 1.4% |
| 448 | Kidney Calculi | 1.3% |
| 449 | Ureteral Calculi | 1.3% |
| 450 | Endometrial Hyperplasia | 1.3% |
| 451 | Pyometra | 1.3% |
| 452 | Vaginitis | 1.3% |
| 453 | Vulvitis | 1.3% |
| 454 | Vaginal Discharge | 1.3% |
| 455 | Vulvodynia | 1.3% |
| 456 | Sexually Transmitted Diseases | 1.3% |
| 457 | Hermaphroditism | 1.3% |
| 458 | Disorders of Sex Development | 1.3% |
| 459 | Maxillary Sinus Neoplasms | 1.2% |
| 460 | Hypospadias | 1.2% |
| 461 | Genital Herpes | 1.2% |
| 462 | Anus Neoplasms | 1.2% |
| 463 | Sigmoid Neoplasms | 1.2% |
| 464 | Candidiasis, Vulvovaginal | 1.2% |
| 465 | Pyelocystitis | 1.1% |
| 466 | Ovarian Diseases | 1.1% |
| 467 | Adnexitis | 1.1% |
| 468 | Cystitis | 1.1% |
| 469 | Hydronephrosis | 1.1% |
| 470 | Hyperoxaluria | 1.1% |
| 471 | Kidney Cortex Necrosis | 1.1% |
| 472 | Kidney Papillary Necrosis | 1.1% |
| 473 | Nephritis | 1.1% |
| 474 | Nephrosclerosis | 1.1% |
| 475 | Nephrosis | 1.1% |
| 476 | Perinephritis | 1.1% |
| 477 | Pruritus Vulvae | 1.1% |
| 478 | Kidney Failure | 1.1% |
| 479 | Uremia | 1.1% |
| 480 | Ureteral obstruction | 1.1% |
| 481 | Ureterocele | 1.1% |
| 482 | Urethral Obstruction | 1.1% |
| 483 | Urethritis | 1.1% |
| 484 | Uterine hemorrhage | 1.1% |
| 485 | Vaginal Fistula | 1.1% |
| 486 | Vesico-Ureteral Reflux | 1.1% |
| 487 | Urinary Retention | 1.1% |
| 488 | Pelvic Inflammatory Disease | 1.1% |
| 489 | Oxalosis | 1.1% |
| 490 | Renal Insufficiency | 1.1% |
| 491 | Uterine Prolapse | 1.1% |
| 492 | Vaginal Prolapse | 1.1% |
| 493 | Pyelonephritis | 1% |
| 494 | Uterine Cervicitis | 1% |
| 495 | Leukorrhea | 1% |
| 496 | Parametritis | 1% |
| 497 | Diabetes Insipidus | 0.9% |
| 498 | Hepatorenal Syndrome | 0.9% |
| 499 | Dyspareunia | 0.9% |
| 500 | Bacteriuria | 0.9% |
| 501 | Diabetic Nephropathy | 0.9% |
| 502 | Glycosuria | 0.9% |
| 503 | Hematuria | 0.9% |
| 504 | Renal hypertension | 0.9% |
| 505 | Oliguria | 0.9% |
| 506 | Polyuria | 0.9% |
| 507 | Proteinuria | 0.9% |
| 508 | Pyuria | 0.9% |
| 509 | Renal Artery Obstruction | 0.9% |
| 510 | Renal Artery Stenosis | 0.9% |
| 511 | Urinary Calculi | 0.9% |
| 512 | Cystocele | 0.9% |
| 513 | Nephrocalcinosis | 0.9% |
| 514 | Urinary Incontinence | 0.9% |
| 515 | Glycosuria, Renal | 0.9% |
| 516 | Enuresis | 0.8% |
| 517 | Bacterial Vaginosis | 0.8% |
| 518 | Gonadal Dysgenesis | 0.8% |
| 519 | Adrenogenital Syndrome | 0.8% |
| 520 | Ovotesticular Disorders of Sex Development | 0.8% |
| 521 | Trichomonas Vaginitis | 0.8% |
| 522 | Uterine Perforation | 0.8% |
| 523 | Ovarian Hyperstimulation Syndrome | 0.8% |
| 524 | Glomerulonephritis | 0.8% |
| 525 | Metrorrhagia | 0.8% |
| 526 | Nephritis, Interstitial | 0.8% |
| 527 | Lipoid nephrosis | 0.8% |
| 528 | Nephrotic Syndrome | 0.8% |
| 529 | Pyelitis | 0.8% |
| 530 | Pyonephrosis | 0.8% |
| 531 | Urethral Stenosis | 0.8% |
| 532 | Nephrogenic Diabetes Insipidus | 0.8% |
| 533 | Congenital Nephrogenic Diabetes Insipidus | 0.8% |
| 534 | Acute kidney injury | 0.8% |
| 535 | Urethral stricture | 0.8% |
| 536 | Hyperandrogenism | 0.8% |
| 537 | AIDS-Associated Nephropathy | 0.7% |
| 538 | Azotemia | 0.7% |
| 539 | Anovulation | 0.7% |
| 540 | Menorrhagia | 0.7% |
| 541 | Albuminuria | 0.7% |
| 542 | Hemoglobinuria | 0.7% |
| 543 | Hypertension, Renovascular | 0.7% |
| 544 | Premature Menopause | 0.7% |
| 545 | Urge Incontinence | 0.7% |
| 546 | Balkan Nephropathy | 0.7% |
| 547 | Focal glomerulosclerosis | 0.7% |
| 548 | Kidney Failure, Chronic | 0.7% |
| 549 | Polycystic Kidney Diseases | 0.6% |
| 550 | Diurnal Enuresis | 0.6% |
| 551 | Renal Aminoacidurias | 0.6% |
| 552 | Fanconi Syndrome | 0.6% |
| 553 | Pseudohypoaldosteronism | 0.6% |
| 554 | Liddle Syndrome | 0.6% |
| 555 | Hemolytic-Uremic Syndrome | 0.6% |
| 556 | Glomerulonephritis, Membranoproliferative | 0.6% |
| 557 | Renal Osteodystrophy | 0.6% |
| 558 | Renal rickets | 0.6% |
| 559 | Turner Syndrome | 0.6% |
| 560 | Chlamydia Infections | 0.5% |
| 561 | Gonorrhea | 0.5% |
| 562 | Renal tubular acidosis | 0.5% |
| 563 | Anti-Glomerular Basement Membrane Disease | 0.5% |
| 564 | Lupus Nephritis | 0.5% |
| 565 | Polycystic Kidney, Autosomal Dominant | 0.5% |
| 566 | Cystinuria | 0.5% |
| 567 | Atypical Hemolytic Uremic Syndrome | 0.5% |
| 568 | Kallmann Syndrome | 0.5% |
| 569 | Syphilis | 0.5% |
| 570 | Zellweger Syndrome | 0.5% |
| 571 | Lymphogranuloma Venereum | 0.4% |
| 572 | Hyperphosphaturia | 0.4% |
| 573 | Klinefelter Syndrome | 0.4% |
| 574 | Familial Hypophosphatemic Rickets | 0.2% |